Stathera
Stathera Raises $55M Series B for MEMS Silicon Timing
Stathera announced $55M in Series B financing on June 30, 2026. Stathera raised a $55 million Series B led by Maverick Silicon to scale production of its GEN2 silicon timing portfolio and develop its AI data center platform.
Round details
The financing includes backing from Maverick Silicon, Celesta Capital, BDC Capital, MediaTek Innovation Fund, TXC Corporation, Ultratech Capital Partners. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $55M
- Total funding reported: $75M
- Headquarters: Montreal, Canada
How the company plans to use the capital
Stathera said it will fund mass production of its GEN2 silicon timing portfolio and accelerate its next-generation AI data center platform. It also plans to grow its engineering and commercial teams and open a Silicon Valley office.
Why this matters for GTM teams
Stathera said precision timing has become strategic infrastructure for AI data centers, where performance depends on keeping data synchronized across processors and the networking that connects them.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Stathera Series B announcement.
Company Info
Investors (6)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


